Moreover, clinicopathological analyses revealed that the combined signature of high Gαh/PLCδ1 levels indicates worse prognosis in patients with breast cancer and correlates with lymph node metastasis of ER-negative breast cancer. This evidence concerns the gene GDA and metastatic malignant neoplasm in the lymph nodes.